Language
English
Bar Admissions
- New York
- New South Wales, Australia
Brigid Morris is a Senior Associate at Gemini. Brigid has extensive experience in patent litigation at large law firms in both the United States and Australia, as well as experience as an in-house government lawyer. Brigid’s practice includes Hatch-Waxman and BPCIA patent litigation, Patent Trial and Appeal Board proceedings, including interferences and inter partes review, patent portfolio management, pre-litigation strategy, and policy and legislative advice. Brigid is dual-qualified and admitted to practice in both the United States (NY) and Australia (NSW).
Brigid spent the first years of her legal career as an IP Litigation associate at Goodwin Procter in NY, gaining valuable experience in Hatch-Waxman litigation, including two District Court trials, as well as general commercial litigation. Following her return to Australia, Brigid practiced in the patent litigation team at DLA Piper in Sydney, where she further grew her experience in Australian patent law, including as a member of the trial team on the largest and most important case addressing damages in pharmaceutical patent cases in Australia. Brigid has also practiced as an in-house government lawyer for AUSTRAC, an Australian regulatory agency, where she advised and counselled internal clients across a broad range of issues, including interpreting legislation, policy guidance, trademark and copyright issues, litigation and managing external legal counsel. Brigid now spends the majority of her time in NY, with the remainder of her time spent back in Australia.
Brigid earned her undergraduate degrees in French, English, and Biomedical Science from the University of Queensland in Brisbane, Australia, and prior to attending law school, worked for a number of years for the Australian Government in the areas of intelligence and international policy.
Ms Morris’ work includes the following representative matters:
- Representing Celltrion in BPCIA proceedings relating to EYLEA (aflibercept).
- Represented Celltrion in successful IPRs related to Actemra (tocilizumab) and EYLEA (aflibercept).
- Represented defendant Teva Pharmaceuticals in patent litigation involving Endo’s OPANA ER® (extended-release oxymorphone hydrochloride) tablets. The case went to trial before the Honorable Richard G. Andrews in July 2016.
- Represented plaintiff Cephalon, Inc. in patent litigation against over fifteen defendants involving Cephalon’s TREANDA® (bendamustine HCl) lyophilized product. The case went to trial before the Honorable Gregory Sleet in December of 2015. After a trial against five defendants, Cephalon prevailed on its claims of infringement against all defendants.
- Represented defendant Pass & Seymour in patent litigation involving ground-fault circuit interrupter products. The case later went to trial, with a jury verdict entered in favor of Pass & Seymour.
- Represented defendant Teva in patent litigation involving teriparatide products. The case resulted in a favorable settlement.
- Represented Wyeth in one of the largest and most complex life sciences patent litigations ever in Australia, involving three separate proceedings against eight separate parties (including the Commonwealth of Australia) in relation to extended release venlafaxine products. These three cases, which involved a six week trial, were the first cases in Australia to address claims on undertakings as to damages in pharmaceutical patent litigation by generic pharmaceutical companies, their suppliers and the Commonwealth of Australia.
- J.D., Boston University School of Law, (cum laude), 2014
- B.S./B.A. Biomedical Science, French and English, The University of Queensland, 2005
- New York
- New South Wales, Australia
- U.S. District Court for the Southern District of New York
- U.S. District Court for the Eastern District of New York
- U.S. Court of Appeals for the Federal Circuit
- G. Joseph Tauro Scholar – awarded to students in the top 10% of their first-year section.
- Legal Writing Fellow
- Symposium Editor – American Journal of Law and Medicine